Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Novo Nordisk A/S ADR (NVO)

Novo Nordisk A/S ADR (NVO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Novo Nordisk A/S ADR Novo Alle 1 Bagsvaerd G7 2880 DNK

www.novonordisk.com P: 45-4444-8888

Description:

Bagsv'rd, Denmark-based Novo Nordisk is a global healthcare company and a leader in the worldwide diabetes market. The company is also a key player in hemophilia care, growth hormone therapy, hormone replacement therapy and obesity.Novo Nordisk operates through two segments: Diabetes and obesity care and Biopharmaceuticals. While the Diabetes and obesity care segment covers insulins, glucagon-like peptide 1 (GLP-1), other protein-related products, obesity and oral anti-diabetic drugs, the Biopharmaceuticals segment includes hemophilia, growth hormone therapy and hormone replacement therapy.Novo Nordisk's most well-known drugs include Levemir, NovoRapid, Victoza, Ozempic, NovoMix, NovoSeven, NovoThirteen, Ryzodeg, Xultophy, Saxenda, Rybelsus, Esperoct, Sogroya and Norditropin, among several others. The company launched its first product for weight management, Saxenda, in the United States in 2015.In August 2018, Novo Nordisk announced that it has acquired all of the shares of Ziylo Ltd.

Key Statistics

Overview:

Market Capitalization, $K 550,844,608
Enterprise Value, $K 552,676,160
Shares Outstanding, K 4,487,532
Annual Sales, $ 33,724 M
Annual Net Income, $ 12,151 M
Last Quarter Sales, $ 9,526 M
Last Quarter Net Income, $ 3,175 M
EBIT, $ 14,894 M
EBITDA, $ 16,261 M
60-Month Beta 0.41
% of Insider Shareholders 0.07%
% of Institutional Shareholders 11.54%
Float, K 4,484,391
% Float 99.93%
Short Volume Ratio 0.50

Growth:

1-Year Return 48.73%
3-Year Return 231.49%
5-Year Return 401.74%
5-Year Revenue Growth 97.23%
5-Year Earnings Growth 114.29%
5-Year Dividend Growth 64.44%

Per-Share Information:

Most Recent Earnings 0.71 on 01/31/24
Latest Earnings Date 05/02/24
Earnings Per Share ttm 2.71
EPS Growth vs. Prev Qtr -2.74%
EPS Growth vs. Prev Year 71.08%
Annual Dividend Rate, $ 0.98
Annual Dividend Yield 0.80%
Most Recent Dividend 0.663 on 03/22/24
Next Ex-Dividends Date 03/22/24
Dividend Payable Date 04/02/24
Dividend Payout Ratio 27.31%
Most Recent Split 2-1 on 09/20/23

NVO Ratios

Ratio
Price/Earnings ttm 46.04
Price/Earnings forward 37.09
Price/Earnings to Growth 2.06
Return-on-Equity % 90.36%
Return-on-Assets % 29.18%
Profit Margin % 36.03%
Debt/Equity 0.25
Price/Sales 16.58
Price/Cash Flow 41.00
Price/Book 35.80
Book Value/Share 3.45
Interest Coverage 124.88

NVO Dividends

Date Value
03/22/24 $0.6630
08/18/23 $0.3120
03/24/23 $0.8470
08/12/22 $0.4070
03/25/22 $0.7410
08/16/21 $0.3870
03/26/21 $0.6630
08/14/20 $0.3680
03/27/20 $0.5610
08/16/19 $0.3180
03/22/19 $0.5570
08/17/18 $0.3270
03/23/18 $0.5780
08/17/17 $0.3360
03/23/17 $0.4790
08/11/16 $0.3310
03/18/16 $0.6990
03/19/15 $0.7599
03/21/14 $0.8390
03/21/13 $3.1838
03/22/12 $2.4970
03/24/11 $1.8176
03/25/10 $1.4066
03/19/09 $1.0345
03/13/08 $0.8841
03/08/07 $1.2181
03/09/06 $0.9661
03/10/05 $0.8399
03/17/04 $0.7446
03/26/03 $0.5229
03/13/02 $0.3685
03/21/01 $0.7950
11/17/00 $0.4700
03/24/00 $0.5850
03/25/99 $0.4100
03/27/98 $0.4020
04/25/97 $0.2810
05/01/96 $0.2150
04/24/96 $0.1800
04/24/95 $0.2100
04/26/94 $0.1400
04/22/93 $0.5400
04/28/92 $0.6000
04/19/91 $0.5090
04/23/90 $0.6240
04/21/89 $0.4630
04/21/88 $0.5220
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar